These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23904397)

  • 1. Impact of age on survival predictability of bone turnover markers in hemodialysis patients.
    Lertdumrongluk P; Lau WL; Park J; Rhee CM; Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Oct; 28(10):2535-45. PubMed ID: 23904397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.
    Rhee CM; Molnar MZ; Lau WL; Ravel V; Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
    Perit Dial Int; 2014; 34(7):732-48. PubMed ID: 24385335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?].
    Jean G; Souberbielle JC; Granjon S; Lorriaux C; Hurot JM; Mayor B; Deleaval P; Chazot C
    Nephrol Ther; 2013 Jun; 9(3):154-9. PubMed ID: 23545236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients.
    Shinaberger CS; Kopple JD; Kovesdy CP; McAllister CJ; van Wyck D; Greenland S; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1769-76. PubMed ID: 18701614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple?
    Delanaye P; Dubois BE; Jouret F; Krzesinski JM; Moranne O; Cavalier E
    Clin Chim Acta; 2013 Feb; 417():35-8. PubMed ID: 23262367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study.
    Fernández-Martín JL; Martínez-Camblor P; Dionisi MP; Floege J; Ketteler M; London G; Locatelli F; Gorriz JL; Rutkowski B; Ferreira A; Bos WJ; Covic A; Rodríguez-García M; Sánchez JE; Rodríguez-Puyol D; Cannata-Andia JB;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1542-51. PubMed ID: 25920921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function.
    Wang M; Obi Y; Streja E; Rhee CM; Lau WL; Chen J; Hao C; Hamano T; Kovesdy CP; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1118-1127. PubMed ID: 28487345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of parathyroid hormone concentration in hemodialysis patients.
    Li J; Molnar MZ; Zaritsky JJ; Sim JJ; Streja E; Kovesdy CP; Salusky I; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Jun; 28(6):1516-25. PubMed ID: 23348879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K; Perrea D; Doumouchtsis S; Tziamalis M; Poulakou M; Vlachos I; Kostakis A
    Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients.
    Sardiwal S; Gardham C; Coleman AE; Stevens PE; Delaney MP; Lamb EJ
    Kidney Int; 2012 Jul; 82(1):100-5. PubMed ID: 22456600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
    Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
    PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.
    Kovesdy CP; Ureche V; Lu JL; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2010 Sep; 25(9):3003-11. PubMed ID: 20299338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Novel Bone Alkaline Phosphatase Isoform B1x Is Associated with Improved 5-Year Survival in Chronic Kidney Disease.
    Haarhaus M; Fernström A; Qureshi AR; Magnusson P
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.
    Dukkipati R; Kovesdy CP; Colman S; Budoff MJ; Nissenson AR; Sprague SM; Kopple JD; Kalantar-Zadeh K
    J Ren Nutr; 2010 Jul; 20(4):243-54. PubMed ID: 20199875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis.
    Qi Q; Monier-Faugere MC; Geng Z; Malluche HH
    Am J Kidney Dis; 1995 Oct; 26(4):622-31. PubMed ID: 7573017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.
    Nakashima A; Yorioka N; Doi S; Masaki T; Ito T; Harada S
    Bone; 2004 Mar; 34(3):579-83. PubMed ID: 15003806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of 1-84 PTH measurement in relation to bone alkaline phosphatase and bone Gla protein in hemodialysis patients.
    Miwa N; Nitta K; Kimata N; Watanabe Y; Suzuki K; Kawashima A; Haga M; Watanabe R; Aoki T; Akiba T; Nihei H
    Nephron Clin Pract; 2003; 94(2):c29-32. PubMed ID: 12845234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High alkaline phosphatase and low intact parathyroid hormone associate with worse clinical outcome in peritoneal dialysis patients.
    Chen Z; Zhang X; Han F; Xie X; Hua Z; Huang X; Lindholm B; Haarhaus M; Stenvinkel P; Qureshi AR; Chen J
    Perit Dial Int; 2021 Mar; 41(2):236-243. PubMed ID: 32363998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased active PTH(1-84) fraction as a predictor of poor mortality in male hemodialysis patients.
    Inaba M; Okuno S; Imanishi Y; Ishimura E; Yamakawa T; Shoji S
    Osteoporos Int; 2013 Nov; 24(11):2863-70. PubMed ID: 24030285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients.
    Zheng CM; Wu CC; Lu CL; Hou YC; Wu MS; Hsu YH; Chen R; Chang TJ; Shyu JF; Lin YF; Lu KC
    Int J Med Sci; 2019; 16(12):1583-1592. PubMed ID: 31839746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.